Skip to search formSkip to main contentSkip to account menu

Polymorphic Post-Transplant Lymphoproliferative Disorder

Known as: Polymorphic B-Cell Lymphoma, Polymorphic PTLD 
A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Post‐transplantation lymphoproliferative disorder (PTLD) is one of the most common de novo malignancies in patients who receive… 
2018
2018
ZusammenfassungUlcera duodeni werden am häufigsten durch eine Helicobacter-pylori-Infektion ausgelöst, gefolgt von… 
Review
2018
Review
2018
Opinion statementPost-transplant lymphoproliferative disorder (PTLD) is one of the most common neoplasms seen after solid organ… 
2013
2013
CHL type is the least common major form of EBV‐related PTLD but rarely occurs in pediatric recipients; development of CHL… 
2011
2011
Post-transplant lymphoproliferative disorder (PTLD) is an increasingly recognized condition as the number of solid organ and bone… 
Review
2009
Review
2009
Post-transplant lymphoproliferative disorder (PTLD) is a well recognized and potentially fatal complication after pediatric… 
2009
2009
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid organ transplantation or, more… 
Highly Cited
2007
Highly Cited
2007
Background. Single-agent rituximab has demonstrated encouraging efficacy and tolerability in posttransplant lymphoproliferative…